|
Volumn 34, Issue SUPPL. 2, 1998, Pages 18-28
|
Cardiovascular effects of alpha-blockers used for the treatment of symptomatic BPH: Impact on safety and well-being
|
Author keywords
Alfuzosin; Benign prostatic obstruction; Doxazosin; Lower urinary tract symptoms; Orthostatic hypotension; Tamsulosin; Terazosin
|
Indexed keywords
ALFUZOSIN;
ALPHA 1 ADRENERGIC RECEPTOR;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
DOXAZOSIN;
TAMSULOSIN;
TERAZOSIN;
SULFONAMIDE;
BLADDER NECK STENOSIS;
BLOOD PRESSURE REGULATION;
CARDIOVASCULAR EFFECT;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
MALE;
ORTHOSTATIC HYPOTENSION;
PRIORITY JOURNAL;
PROSTATE HYPERTROPHY;
SLOW RELEASE FORMULATION;
SYMPTOM;
WELLBEING;
BLADDER OBSTRUCTION;
BLOOD PRESSURE;
DRUG EFFECT;
REVIEW;
HEMODYNAMICS;
ADRENERGIC ALPHA-ANTAGONISTS;
BLOOD PRESSURE;
HUMANS;
MALE;
PROSTATIC HYPERPLASIA;
SULFONAMIDES;
URINARY BLADDER NECK OBSTRUCTION;
HEMODYNAMIC PROCESSES;
|
EID: 0031660105
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000052284 Document Type: Conference Paper |
Times cited : (41)
|
References (87)
|